| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2012 | EP2416788A2 Coupled identification and treatment of cancer |
| 02/15/2012 | EP2416785A1 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions |
| 02/15/2012 | EP2416784A2 Compounds that suppress cancer cells and exhibit antitumor activity |
| 02/15/2012 | EP2416783A1 Improved glucocorticoid therapy |
| 02/15/2012 | EP2416782A1 Controlled-release clozapine compositions |
| 02/15/2012 | EP2416781A1 Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer |
| 02/15/2012 | EP2416780A1 Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer |
| 02/15/2012 | EP2416779A1 Method of predicting a predisposition to qt prolongation based on bai3 gene sequence or product thereof |
| 02/15/2012 | EP2416778A1 Method of predicting a predisposition to qt prolongation based on abcc2 gene sequence or product thereof |
| 02/15/2012 | EP2416777A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives |
| 02/15/2012 | EP2416776A2 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 02/15/2012 | EP2416775A1 Active pharmaceutical ingredient adsorbed on solid support |
| 02/15/2012 | EP2416774A1 Treatment regimen utilizing neratinib for breast cancer |
| 02/15/2012 | EP2416773A1 Checkpoint kinase 1 inhibitors for potentiating dna damaging agents |
| 02/15/2012 | EP2416772A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent |
| 02/15/2012 | EP2416771A2 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis |
| 02/15/2012 | EP2416770A1 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds |
| 02/15/2012 | EP2416769A1 Method for preparing molecular complexes between adapalene and cyclodextrins |
| 02/15/2012 | EP2416768A1 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof |
| 02/15/2012 | EP2416767A2 Compositions and methods for bioactive coatings to improve allograft incorporation |
| 02/15/2012 | EP2416766A2 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
| 02/15/2012 | EP2416765A1 Hcv inhibitor and therapeutic agent combinations |
| 02/15/2012 | EP2416761A1 Desfesoterodine in the form of a tartaric acid salt |
| 02/15/2012 | EP2416760A1 Lipid compositions |
| 02/15/2012 | EP2416759A2 Stable pharmaceutical compositions of diclofenac |
| 02/15/2012 | EP2416756A2 Stable pharmaceutical compositions with high bioavailibility |
| 02/15/2012 | EP2416755A1 Melting tablet containing a sildenafil salt |
| 02/15/2012 | EP2416661A1 Inhibitors of bacterial type iii secretion system |
| 02/15/2012 | EP2416660A1 Inhibitors of fatty acid amide hydrolase |
| 02/15/2012 | EP2416658A1 Photo-activated attachment of cholesterol to polyurethane surfaces for adhesion of endothelial cells |
| 02/15/2012 | EP2416657A1 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof |
| 02/15/2012 | EP2416656A1 Methods for preventing and/or treating lysosomal storage disorders |
| 02/15/2012 | EP2416655A1 Methods for preventing and/or treating degenerative disorders of the central nervous system |
| 02/15/2012 | EP2416652A1 Methods of delivering oligonucleotides to immune cells |
| 02/15/2012 | EP2416651A1 Methods of treating edema related to ischemia-reperfusion |
| 02/15/2012 | EP2416650A1 Nanoparticle formulations and uses therof |
| 02/15/2012 | EP2321286B1 Substituted n-oxide pyrazine derivatives |
| 02/15/2012 | EP2288606B1 New co-crystal compound of rivaroxaban and malonic acid |
| 02/15/2012 | EP2213666B1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application |
| 02/15/2012 | EP2194991B1 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax |
| 02/15/2012 | EP2170831B1 Benzazepine derivatives useful as vasopressin antagonists |
| 02/15/2012 | EP2142192B1 Compositions and kits for treating influenza |
| 02/15/2012 | EP2124944B1 Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
| 02/15/2012 | EP2117553B8 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
| 02/15/2012 | EP2102217B1 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 02/15/2012 | EP2073806B1 Use of spiro-oxindole compounds as therapeutic agents |
| 02/15/2012 | EP2062575B1 Adhesive preparation comprising desglymidodrine |
| 02/15/2012 | EP2034991B1 Preparation for preventing ageing symptoms containing phytoestrogens and melatonin |
| 02/15/2012 | EP2027107B1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 02/15/2012 | EP1963259B1 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 02/15/2012 | EP1962868B1 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 02/15/2012 | EP1957083B1 Beta glycolipids as immuno-modulators |
| 02/15/2012 | EP1951891B1 Cancer antigen mage-a9 and uses thereof |
| 02/15/2012 | EP1931222B1 Gelling compositions and methods |
| 02/15/2012 | EP1885333B1 Pharmaceutical formulation of apomorphine for buccal administration |
| 02/15/2012 | EP1865961B1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
| 02/15/2012 | EP1831199B1 MMP inhibitors |
| 02/15/2012 | EP1819680B1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 02/15/2012 | EP1811038B1 Process for producing cellooligosaccharide |
| 02/15/2012 | EP1797077B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| 02/15/2012 | EP1781255B1 Compositions and methods for treating leukemia |
| 02/15/2012 | EP1771441B8 Novel carboxamides for use as xa inhibitors |
| 02/15/2012 | EP1768666B1 Novel uses of porphyrin compounds |
| 02/15/2012 | EP1755572B1 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 02/15/2012 | EP1735268B1 Opioid receptor antagonists |
| 02/15/2012 | EP1727795B1 Process for the production of atorvastatin calcium in amorphous form |
| 02/15/2012 | EP1678212B1 Hypo- and hyper-acetylated meningococcal capsular saccharides |
| 02/15/2012 | EP1644019B1 Abuse resistant amphetamine compounds |
| 02/15/2012 | EP1638577B1 Pharmaceutical preparation for treating tropical parasitic diseases containing diaminazen-diaceturate |
| 02/15/2012 | EP1633695B1 Smooth muscle spasmolytic agents |
| 02/15/2012 | EP1601362B1 Use of diazoxide in the treatment of ischemia retinae |
| 02/15/2012 | EP1532161B1 Vectors for expression of hml-2 polypeptides |
| 02/15/2012 | EP1488795B1 Remedies for lung cancer |
| 02/15/2012 | EP1395595B1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative |
| 02/15/2012 | EP1328293B1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 02/15/2012 | CN1942472B 回折拟态及其相关方法 Mimicry and related methods folded back |
| 02/15/2012 | CN1939419B 一种由连翘和新鱼腥草素钠制成的药物组合物 One kind Houttuyfonate by forsythia and new pharmaceutical composition made of sodium |
| 02/15/2012 | CN1918127B 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 The introduction of a cyclic compound having a substituted or unsubstituted 4-pyridyl amino alkylthio |
| 02/15/2012 | CN1847228B 奥扎格雷鸟氨酸盐及其注射剂型 Orszag Thunderbird acid salts and injectable forms |
| 02/15/2012 | CN1696124B 制备二氟苯并-1,3-间二氧杂环戊烯-5-羧酸衍生物的方法 Preparation of 1,3-difluorophenyl and dioxole-5-carboxylic acid derivative of the |
| 02/15/2012 | CN102356085A Imidazothiazole derivative having proline ring structure |
| 02/15/2012 | CN102356084A N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same |
| 02/15/2012 | CN102356083A Use of kinase inhibitor for treatment of thymoma |
| 02/15/2012 | CN102356082A 3, 3' -spiroindolinone derivatives as anticancer agents |
| 02/15/2012 | CN102356081A Bicyclic compounds for the reduction of beta-amyloid production |
| 02/15/2012 | CN102356080A Amorphous salt of macrocyclic inhibitor of hcv |
| 02/15/2012 | CN102356079A Amide derivatives as neuropeptide y5 receptor ligands |
| 02/15/2012 | CN102356075A Compositions and methods for inhibition of the jak pathway |
| 02/15/2012 | CN102356074A Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics |
| 02/15/2012 | CN102356071A Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production a novel alpha-(n-sulfonamido) acetamide compound incorporating deuterium as inhibitor of beta amyloid peptide production |
| 02/15/2012 | CN102356070A Process for preparation of pyrazole derivatives |
| 02/15/2012 | CN102356068A 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 02/15/2012 | CN102356065A Piperidine derivatives as nk3 receptor antagonists |
| 02/15/2012 | CN102356061A Method for producing bicyclic g-amino acid derivative |
| 02/15/2012 | CN102356057A Use of derivatives of polyunsaturated fatty acids as medicaments |
| 02/15/2012 | CN102355910A Composition for improving inflammatory disease using abh antigens |
| 02/15/2012 | CN102355903A A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment |
| 02/15/2012 | CN102355902A Treatment of neurotrophic factor mediated disorders |
| 02/15/2012 | CN102355901A Compound for the treatment of tuberculosis |
| 02/15/2012 | CN102355900A Administration regime for nitrocatechols |